Screener
Bausch Health Companies BHC Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Proceeds from sale of marketable securities | 1 | 4 |
| Proceeds from sale of assets and businesses, net of costs to sell | 3 | — |
| Interest settlements from cross-currency swaps | 5 | 6 |
| Net cash used in investing activities | (139) | (130) |
| Cash Flows From Financing Activities | ||
| Issuance of long-term debt, net of discounts | 2,802 | 50 |
| Repayments of long-term debt | (2,857) | (168) |
| Payments of employee withholding taxes related to share-based awards | (34) | (16) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's investing cash flow?
- Bausch Health Companies (BHC) reported investing cash flow of -$139M in Q1 2026.
- How has Bausch Health Companies's investing cash flow changed year-over-year?
- Bausch Health Companies's investing cash flow decreased by 6.9% year-over-year, from -$130M to -$139M.
- What is the long-term trend for Bausch Health Companies's investing cash flow?
- Over 3 years (2022 to 2025), Bausch Health Companies's investing cash flow has grown at a 25.2% compound annual growth rate (CAGR), from -$303M to -$595M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Bausch Health Companies's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude